Increased sensitivity of HIV-1 antibody detection

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1258-

  Urnovitz, Howard B ^a   Sturge, Jerrilyn C ^a   Gottfried, Toby D ^a  

^a Calypte Biomedical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; URINALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1842407855     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1258     Document Type: Article

References (34)

1. + T cells. Science 270, 1811-1815 (1995).
2. Feng, Y., Broder, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996).
3. Alkhatib, G., et al. CC CRK5: A RANTES, MIP-1 α, MIP-1 β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).
4. Choe, H., et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).
5. Deng, H., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).
6. Doranz, B.J., et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CRK-2b as fusin cofactors. Cell 85, 1149-1158 (1996).
7. + cells is mediated by the chemokine receptor CC-CRK-5. Nature 381, 667-673 (1996).
8. Liao, F., et al. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015-2023 (1997).
9. Connor, R.I., Sheridan, K.E., Ceradini, D., Choe, S. & Landau, N.R. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185, 621-628 (1997).
10. Heredia, A., Vallejo, A., Soriano, V., Epstein, J.S. & Hewlett, I.K. Chemokine receptors and HIV-2. AIDS 11, 1198-1199 (1997).
11. Chen, Z., Zhou, P., Ho, D.D., Landau, N.R. & Marx, P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71, 2705-2714 (1997).
12. Bleul, C.C., et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
13. Oberlin, E., et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835 (1996).
14. Endres, M.J., et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756 (1996).
15. Cocchi, F., et al. The V3 domain of HIV-1 envelope glycoprotein gp120 is critical for chemokine-mediated blockade of infection. Nature Med. 2, 1244-1247 (1996).
16. Valentin, A., Albert, J., Fenyö, E.M. & Åsjö, B. Dual tropism for macrophages and lymphocytes is a common feature of primary HIV-1 and HIV-2 isolates. J. Virol 68, 6684-6689 (1994).
17. Schmidtmayerova, H., Sherry, B. & Bukrinsky, M. Chemokines and HIV replication. Nature 382, 767 (1996).
18. + T-cell-derived factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA 93, 15341-15345 (1996).
19. Verani, A., et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185, 805-816 (1997).
20. de Jong, J.-J., de Ronde, A., Keulen, W., Tersmette, M. & Goudsmit, J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution. J. Virol. 66, 6777-6780 (1992).
21. Fouchier, R.A.M., et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66, 3183-3187 (1992).
22. Wu, L., et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature 384, 179-183 (1996).
23. Trkola, A., et al. CD4-dependent, antibody-sensitive interaction between HIV-1 and its co-receptor CCR5. Nature 384, 184-187 (1996).
24. Åsjö, B., et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii, 660-662 (1986).
25. Koot, M., et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann. Intern. Med. 118, 681-688 (1993).
26. Scarlatti, G., et al. Polymerase chain reaction, virus isolation and antigen assay in HIV-1 antibody positive mothers and their children. AIDS 5, 1173-1178 (1991).
27. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morbid. Mortal. Wkly. Rep. 43, 1-10 (1994).
28. Martin, N., et al. Workshop on perinatally acquired human immunodeficiency virus infection in long-term surviving children: A collaborative study of factors contributing to slow disease progression. AIDS Res. Hum. Retroviruses 12, 1565-1570 (1996).
29. Scarlatti, G., et al. Mother-to-child transmission of human immunodeficiency virus type 1: Correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168, 207-210 (1993).
30. Harada, S., Koyanagi, Y. & Yamamoto, N. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566 (1985).
31. Rosen, C.A., Sodroski, J.G., Campbell, K. & Haseltine, W. A. Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes. J. Virol. 57, 379-384 (1986).
32. Clapham, P.R., Blanc, D. & Weiss, R. A. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181, 703-715 (1991).
33. Scarlatti, G., et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc. Natl. Acad. Sci. USA 90, 1721-1725 (1993).
34. Myers, G., Korber, B., Berzofsky, J.A., Smith, R.F. & Pavlakis, G.N. in: Human retroviruses and AIDS: A compilation and analysis of nucleic acids and amino acid sequences. (Los Alamos Natl. Laboratories, Los Alamos, NM, 1995).